GURUFOCUS.COM » STOCK LIST » Basic Materials » Forest Products » Quintis Ltd (GREY:TFSCY) » Definitions » EPS (Diluted)

Quintis (Quintis) EPS (Diluted) : $-20.30 (TTM As of Jun. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Quintis EPS (Diluted)?

Quintis's Earnings per Share (Diluted) for the six months ended in Jun. 2017 was $-21.61. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2017 was $-20.30.

Quintis's EPS (Basic) for the six months ended in Jun. 2017 was $-21.61. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2017 was $-20.27.

Quintis's EPS without NRI for the six months ended in Jun. 2017 was $-21.61. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2017 was $-20.30.

During the past 12 months, Quintis's average EPS without NRIGrowth Rate was -528.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Quintis's highest 3-Year average EPS without NRI Growth Rate was 53.00% per year. The lowest was 0.00% per year. And the median was 7.90% per year.


Quintis EPS (Diluted) Historical Data

The historical data trend for Quintis's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quintis EPS (Diluted) Chart

Quintis Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.71 5.65 6.42 4.63 -20.23

Quintis Semi-Annual Data
Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.42 3.60 0.95 1.31 -21.61

Competitive Comparison of Quintis's EPS (Diluted)

For the Lumber & Wood Production subindustry, Quintis's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quintis's PE Ratio Distribution in the Forest Products Industry

For the Forest Products industry and Basic Materials sector, Quintis's PE Ratio distribution charts can be found below:

* The bar in red indicates where Quintis's PE Ratio falls into.



Quintis EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Quintis's Diluted EPS for the fiscal year that ended in Jun. 2017 is calculated as

Diluted EPS (A: Jun. 2017 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-315.256-0)/15.579
=-20.24

Quintis's Diluted EPS for the quarter that ended in Jun. 2017 is calculated as

Diluted EPS (Q: Jun. 2017 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-336.675-0)/15.611
=-21.57

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2017 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-20.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quintis  (GREY:TFSCY) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Quintis EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Quintis's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Quintis (Quintis) Business Description

Traded in Other Exchanges
N/A
Address
171-173 Mounts Bay Road, Level 2, Perth, WA, AUS, 6000
Quintis Ltd engages in the cultivation of Indian sandalwood and production of sandalwood oil. It operates in four segments. The Plantation Management segment which dominates firm's revenue is responsible for the promotion and sales of Indian sandalwood lots; establishment, maintenance, and harvesting of Indian Sandalwood plantations on behalf of the growers and group owned plantations; and end-market research and establishment of end-market agreements. The Finance segment provides financial assistance to growers to purchase sandalwood lots. The Sandalwood Products segment manufactures sandalwood oil and products for resale. The Pharmaceutical segment focuses in the research and development of pharmaceutical and biopharmaceutical products for commercializing.

Quintis (Quintis) Headlines

No Headlines